Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT02116335

Endothelin Receptor Function and Acute Stress

Endothelin Receptor Function and Acute Stress (End-Stress)

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
320 (estimated)
Sponsor
Augusta University · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Our bodies respond differently to stress. Animal studies by the investigators have found that endothelin-1 plays a role in regulating blood pressure in response to stress. This study is an extension of the investigators previous animal work to evaluate the role of endothelin-1 during stress in humans.

Detailed description

Using a salt sensitive animal model of prehypertension, the Dahl S rat,the investigators have previously published that acute stress elicits a pressor response that is accompanied by an increase in 8 isoprostane and endothelin-1. However, the pressor response is suppressed by endothelin A/B receptor antagonism. Moreover, the investigators have identified that the increase in 8-isoprostane occurs downstream of endothelin receptor activation. These data indicate that endothelin receptor activation is a main player In the pressor response to acute stress in pre-hypertensive animals; however, this phenomenon has yet to be elucidated in humans.

Conditions

Interventions

TypeNameDescription
DRUGBosentanStress response and vascular function will be assessed 3 days following 125 mg twice per day of Bosentan
DRUGPlaceboStress response and vascular function will be assessed 3 days following twice per day placebo

Timeline

Start date
2015-06-01
Primary completion
2025-12-01
Completion
2026-01-01
First posted
2014-04-16
Last updated
2025-01-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02116335. Inclusion in this directory is not an endorsement.

Endothelin Receptor Function and Acute Stress (NCT02116335) · Clinical Trials Directory